BSP :: Inflammation & Allergy

Manuscripts should be submitted openly to one of the following Editors without prior invitation at the following addresses:

Editor for North America:
William M. Selig, Ph.D.
Senior Director
Pre-Clinical Development
Magen BioSciences
100 Beaver Street
Suite 101
Waltham, MA 02453
USA
Tel: 781-314-2932
Fax: 781-314-2999
Email: bselig@magenbiosciences.com

Editor for UK/Europe/Africa:
Prof. Stephen Holgate
MRC Clinical Professor of Immunopharmacology
Medical Specialties
Level D, Centre Block
Mail Point 810
Southampton General Hospital
Tremona Road
Southampton SO16 6YD
UK
Tel: +44-2380-796-960
Fax: +44-2380-701-771
E-mail: sth@soton.ac.uk

Editor for Australia/New Zealand
Dr. Charles MacKay
Director, Arthritis & Inflammation Research Program
The Garvan Institute of Medical Research
384 Victoria Street, Darlinghurst
NSW 2010
Australia
Tel: +61-2-9295-8405
Fax: +61-2-9295-8404
E-mail: c.mackay@garvan.unsw.edu.au

Regional Editor (Asia)
Kenji Izuhara, M.D., Ph.D.
Professor
Division of Medical Biochemistry
Department of Biomolecular Sciences
Saga Medical School
5-1-1, Nabeshima, Saga, 849-8501
Japan
TEL: +81-952-34-2261
FAX: +81-952-34-2058
E-mail: kizuhara@cc.saga-u.ac.jp

Full manuscripts should only be sent to the Regional Editors and not to the Editor-in-Chief.

Manuscripts fall under two categories:
1. Invited Reviews (Full length & Mini-reviews)
The focus will either be the therapeutic target or the molecular target which may be a single protein or a family of proteins. The authors will have considerable liberty to discuss such areas as genomics, polymorphisms, molecular biology, creation and use of stable cell lines, target validation (e.g. cellular and sub-cellular distribution of the molecular target, embryonic and functional knockout animal models, antisense and aptamer studies), high throughput screening and drug discovery, rational drug design, drug discovery and development, and the results of clinical trials that shed light on the relationship between the molecular and therapeutic target. Manuscripts will be reviewed by at least two reviewers to ensure that only articles of the highest scientific quality appear in Inflammation & Allergy - Drug Targets.

2. Unsolicited Reviews (Full length & Mini-reviews)
Manuscripts on any topic related to inflammation and allergy drug targets will be considered by the Inflammation & Allergy - Drug Targets editorial team.

For full length review articles, the manuscript, written in English, should not exceed 60 pages (ca. 30 printed pages) and for mini-reviews a maximum of 30 manuscript pages in length (ca. 15 printed pages). The manuscript should be typed in double spacing throughout on A-4 or US Letter (8.5x11 inches) paper. All pages should be numbered. Abbreviations should be defined the first time that they are used in the manuscript and a list of abbreviations used should be provided.

Manuscript Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. This should be followed by the Acknowledgement (if any) and Reference sections. The first page should contain the title, the authors’ names (initials and surname only), with an asterisk to mark the name of the principal author.

COVERING LETTER: It is a mandatory requirement that a signed covering letter also be submitted along with the manuscript by the author to whom correspondence is to be addressed, delineating the scope of the submitted article declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors'. All inconsistencies in the text and in the reference section, and any typographical errors must be carefully checked and corrected before the submission of the manuscript. The article contains no such material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the agreement. The authors acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the agreement. Download the Covering letter

Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.

ACKNOWLEDGEMENTS: Please acknowledge anyone (individual/company/institution) who has contributed to the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section.

This journal complies with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals http://www.icmje.org and the FDA's Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices http://www.fda.gov/oc/op/goodreprint.html

Abstract: The abstract should not exceed 250 words and it should condense the essential features of the review article, with the focus on the major advances in the field.

Key Words: Authors must supply up to eight key words along with their manuscript.

Text: The main text should begin on a separate page and it may be subdivided into separate sections. The review article should mention any previous important reviews in the field and contain a comprehensive discussion starting with the general background of the field. It should then go on to discuss the salient features of recent developments. The authors should avoid presenting material which has already been published in any previous review. The reference numbers should be given in square brackets in the text. Acknowledgements should be kept to a minimum.

Data tables should be submitted in Microsoft Excel or in Microsoft Word table format.
Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
Tables should not contain vertical rules.
Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
Tabular data provided as additional files can be submitted as an Excel spreadsheet.

Figures/Illustrations: All authors must strictly follow the guidelines below for preparing illustrations for publication in Inflammation & Allergy - Drug Targets. If the figures are found to be sub-standard, then the manuscripts will be rejected/and the authors offered the option of figure improvement professionally by Bentham Publishing Services. The costs for such improvement will be charged to the authors.

The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. The acceptance of a manuscript for publication is subject to the figures being up to the highest standards in terms of clarity and resolution. In case the figures supplied are not up to the standards required, then the manuscripts will be rejected, and the authors given the option to either return the manuscripts within one week with appropriate drawings/figures or they may opt to have these professionally prepared through the paid professional service available from Bentham Publishing Services.

Submit the original artwork or a photographic print of the original for publication.
Do not submit photocopies. (Hardcopy submission requirement).
Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
Good quality of hardcopy originals are a requirement.
Figures/illustrations cannot be modified or enhanced by the journal production staff.
Figures should be referred to as “Fig. (1)”, “Fig. (2)” etc. in the text with figure numbers in bold within round bracket.
Revised manuscripts should contain a complete set of artwork and photographs.

The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF.
Illustrations must fit a single or double column format on the journal page, according to the following guideline below:

	HEIGHT	WIDTH
SINGLE COLUMN	24 cm (max)	8.5 cm (max)
DOUBLE COLUMN	24 cm (max)	18 cm (max)

Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
Avoid textures and shadings giving a three-dimensional effect to the illustration.
Symbols and lettering in the illustration should be of similar size.
Smaller lettering is used.
Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
Do not use lines thinner than 1 point.

The cost for the first published page of color figures is US $893; the second additional page will be US $652; and each subsequent page, US $441.
Color figures should be supplied in CMYK not RGB colors.
Required resolution for online submission is 300 dpi. In case of hardcopy submission, please use the maximum resolution available.

Photographs: Submit high-contrast prints that are of single- or double-column width so that they will not have to be reduced when printed. Negatives are not acceptable. However, in case of hardcopy submission, color illustrations and plates can be published from 35 mm color slides.

Chemical Structures: Chemical structures must be prepared according to the guidelines below.

Structures should be prepared using a suitable drawing program e.g. ChemDraw and provided as separate file, submitted both on disk and in printed formats.

Numbers in bold should identify all chemical structure. If a name is also used to describe the compound, the associated number in bold should be in parenthesis, e.g. “compound (1)”.

Structure Drawing Preferences:

Scale 100%

References: For the format of references, see the ACS Style Guide, pp 106-114,

Journal Reference:
Thomsen, R.; Christensen, M.H. MolDock: a new technique for high-accuracy molecular docking. J. Med. Chem., 2006, 49, 3315-21.

Book Reference:
Rahman, A.-U.; Shah, Z. Stereoselective Synthesis in Organic Chemistry, Springer-Verlag: New York, 1993.

Book Chapter Reference:
Wheeler, D.M.S.; Wheeler, M.M. In Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Science B. V: Amsterdam, 1994; Vol. 14, pp. 3-46.

Abstracts, unpublished data and personal communications (which can only be included if the permission has been obtained) should not be given in the reference section but they may be mentioned in the text with details provided as footnotes. All authors of referenced papers must be cited and there must be no use of the short hand version of et al. when citing the authors.

SUPPORTIVE/SUPPLEMENTARY MATERIAL: We do encourage to append supportive material, for example a PowerPoint file containing a talk about the study, a PowerPoint file containing additional screenshots, a Word, RTF, or PDF document showing the original instrument(s) used, a video, or the original data (SAS/SPSS files, Excel files, Access Db files etc.) provided it is inevitable or endorsed by the journal's Editor.

Published/reproduced material should not be included unless you have obtained written permission from the copyright holder, which must be forwarded to the Editorial Office in case of acceptance of your article for publication.

Supportive/Supplementary material intended for publication must be numbered and referred to in the manuscript but should not be a part of the submitted paper. In-text citations as well as a section with the heading "Supportive/Supplementary Material" before the "References" section should be provided. Here, list all Supportive/Supplementary Material and include a brief caption line for each file describing its contents.

Any additional files will be linked into the final published article in the form supplied by the author, but will not be displayed within the paper. They will be made available in exactly the same form as originally provided only on our Web site. Please also make sure that each additional file is a single table, figure or movie (please do not upload linked worksheets or PDF files larger than one sheet). Supportive/Supplementary material must be provided in a single zipped file not larger than 4 MB.

Authors must clearly indicate if these files are not for publication but meant for the reviewers'/editors' perusal only.

Online Manuscript Submission: (preferable) An online submission and tracking service via Internet facilitates a speedy and cost-effective submission of manuscripts.¹ The full manuscript has to be submitted online via Bentham's Content Management System (CMS) at www.bentham-editorial.org/ View Instructions

Alternatively, you may also submit your full manuscript by e-mail to cdtia@benthamscience.org

Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The principal/corresponding author will be required to submit a Covering Letter along with the manuscript, on behalf of all the co-authors (if any). The author(s) will confirm that the manuscript (or any part of it) has not been published previously or is not under consideration for publication elsewhere. Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained.

For all online submissions, please provide your complete manuscript in the form of a single zipped folder containing soft copies of all the materials (main text in MS Word or Tex/LaTeX), figures/illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw (CDX)/ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be included, embedded with all the figures/illustrations/tables/chemical structures etc.

A successful electronic submission of a manuscript will be followed by a system-generated acknowledgement to the principal/corresponding author within 72 hours of the dispatch of the manuscript. Any queries therein should be addressed to mahmood@bentham.org and copied to Jalil@bentham.org

Page Charges: No page charges will be levied to authors.

Language Editing: Manuscripts submitted containing many English typographical errors will not be published. Authors from non-English language countries are advised to use the services of our professional language editing department prior to submitting their manuscript to the Journal. Please contact Bentham Publishing Services www.benthampublishingservices.com for a language editing quote at e-mail: info@benthampublishingservices.com stating the total number of words of the article to be edited.

Proofs: Authors are sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Authors will be charged for excessive changes made at the page proof stage.

Reprints: Each first-named (corresponding) author will receive electronically a certain number of free reprints. Reprints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org

Open Access Plus: Accepted articles can be published online for free open access for all to view. Open access publishing provides the maximum dissemination of the article to the largest audience. Authors must pay for this service. All corresponding authors will be asked to indicate whether or not they wish to pay to have their paper made freely available on publication. If authors do not select the Open Access option, then their article will be published with standard subscription-based access at no charge.

Bentham Science offers authors the choice of open access publication of their articles at a fee of US$ 2,800 per published article which allows indefinite free-to-view online publication with Bentham Science.

For more information please contact us at e-mail: openaccess@bentham.org

Reviewing and Promptness of Publication: All papers submitted for publication will be immediately subjected to editorial scrutiny, usually in consultation with members of the Editorial Advisory Board. Every effort will be made to assess the papers quickly. The papers will be typeset and the proofs dispatched to the authors normally within 4 weeks of their acceptance.

Copyright: Authors who publish in Bentham print & online journals will transfer copyright to their work to Bentham Science Publishers. Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Covering Letter or the Terms and Conditions. It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication. Once submitted to the journal, the author will not withdraw their manuscript at any stage prior to publication.

E-Pub Ahead of Schedule: Bentham Science Publishers are pleased to offer electronic publication of accepted papers prior to scheduled publication. These peer-reviewed papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule sections have been peer-reviewed and accepted for publication in this journal and posted online before scheduled publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Bentham Science Publishers, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained of articles in the E-Pub Ahead-of-Schedule.